Glenview Capital Management - Q1 2020 holdings

$3.68 Billion is the total value of Glenview Capital Management's 44 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 44.0% .

 Value Shares↓ Weighting
TAK SellTAKEDA PHARMACEUTICAL CO LTDsponsored ads$302,947,000
-49.8%
19,956,999
-34.7%
8.24%
+55.9%
THC  TENET HEALTHCARE CORP$284,193,000
-62.1%
19,735,6250.0%7.73%
+17.6%
CI SellCIGNA CORP NEW$260,058,000
-69.6%
1,467,759
-64.9%
7.07%
-5.4%
BHC  BAUSCH HEALTH COS INC$257,564,000
-48.2%
16,617,0080.0%7.00%
+60.9%
HCA SellHCA HEALTHCARE INC$252,719,000
-71.3%
2,812,681
-52.8%
6.87%
-11.0%
MCK SellMCKESSON CORP$222,115,000
-56.7%
1,642,134
-55.8%
6.04%
+34.3%
IQV SellIQVIA HLDGS INC$184,908,000
-68.1%
1,714,333
-54.3%
5.03%
-0.9%
FMC SellF M C CORP$158,700,000
-47.6%
1,942,713
-35.9%
4.31%
+62.8%
DXC  DXC TECHNOLOGY CO$143,375,000
-65.3%
10,986,5620.0%3.90%
+7.8%
HOLX SellHOLOGIC INC$137,261,000
-73.9%
3,910,580
-61.2%
3.73%
-18.9%
VIAC SellVIACOMCBS INCcl b$130,077,000
-79.4%
9,284,589
-38.4%
3.54%
-36.2%
HUM SellHUMANA INC$105,493,000
-72.8%
335,945
-68.3%
2.87%
-15.6%
NUAN SellNUANCE COMMUNICATIONS INC$102,572,000
-58.0%
6,112,735
-55.4%
2.79%
+30.4%
FLEX SellFLEX LTDord$98,359,000
-61.7%
11,744,352
-42.3%
2.67%
+19.0%
MTOR  MERITOR INC$95,499,000
-49.4%
7,207,4350.0%2.60%
+57.1%
FISV SellFISERV INC$79,716,000
-61.3%
839,208
-52.9%
2.17%
+20.1%
BSX NewBOSTON SCIENTIFIC CORP$77,916,0002,387,859
+100.0%
2.12%
UNH SellUNITEDHEALTH GROUP INC$70,252,000
-68.4%
281,705
-62.8%
1.91%
-2.0%
ABC SellAMERISOURCEBERGEN CORP$65,313,000
-68.0%
738,000
-69.2%
1.78%
-0.4%
CNC SellCENTENE CORP DEL$55,932,000
-8.9%
941,457
-3.5%
1.52%
+183.2%
BKD  BROOKDALE SR LIVING INC$55,017,000
-57.1%
17,633,5720.0%1.50%
+33.3%
CAR SellAVIS BUDGET GROUP$46,490,000
-80.0%
3,344,576
-53.5%
1.26%
-37.8%
GOOGL SellALPHABET INCcap stk cl a$41,288,000
-86.0%
35,533
-83.8%
1.12%
-56.5%
URI BuyUNITED RENTALS INC$40,705,000
+107.0%
395,583
+235.5%
1.11%
+543.6%
BAX NewBAXTER INTL INC$39,197,000482,786
+100.0%
1.07%
MOH NewMOLINA HEALTHCARE INC$38,937,000278,702
+100.0%
1.06%
GPN SellGLOBAL PMTS INC$36,759,000
-46.9%
254,865
-32.8%
1.00%
+64.9%
ENDP SellENDO INTL PLC$35,822,000
-58.6%
9,681,598
-47.6%
0.97%
+28.5%
UHS BuyUNIVERSAL HLTH SVCS INCcl b$35,111,000
+45.4%
354,375
+110.5%
0.95%
+352.1%
ESI SellELEMENT SOLUTIONS INC$33,836,000
-61.6%
4,047,333
-46.3%
0.92%
+19.3%
CTVA SellCORTEVA INC$33,289,000
-67.8%
1,416,562
-59.5%
0.90%
-0.1%
MSFT SellMICROSOFT CORP$33,037,000
-0.5%
209,477
-0.5%
0.90%
+208.6%
EBAY SellEBAY INC$25,133,000
-72.0%
836,096
-66.3%
0.68%
-12.9%
MYGN SellMYRIAD GENETICS INC$22,031,000
-76.5%
1,539,531
-55.3%
0.60%
-27.0%
 NUANCE COMMUNICATIONS INCdbcv 1.000%12/1$19,122,000
-4.6%
20,000,0000.0%0.52%
+197.1%
NSP BuyINSPERITY INC$16,439,000
-18.8%
440,733
+87.2%
0.45%
+152.5%
PACB SellPACIFIC BIOSCIENCES CALIF IN$9,879,000
-49.6%
3,228,495
-15.3%
0.27%
+57.3%
ISRG NewINTUITIVE SURGICAL INC$7,319,00014,779
+100.0%
0.20%
CHRS NewCOHERUS BIOSCIENCES INC$6,922,000426,738
+100.0%
0.19%
MIK BuyMICHAELS COS INC$4,183,000
-12.4%
2,582,377
+337.5%
0.11%
+171.4%
ABT NewABBOTT LABS$3,689,00046,752
+100.0%
0.10%
MDT NewMEDTRONIC PLC$3,578,00039,671
+100.0%
0.10%
EW NewEDWARDS LIFESCIENCES CORP$3,189,00016,906
+100.0%
0.09%
LOW SellLOWES COS INC$2,550,000
-98.2%
29,630
-97.5%
0.07%
-94.5%
PRAH ExitPRA HEALTH SCIENCES INC$0-252,983
-100.0%
-0.25%
FB ExitFACEBOOK INCcl a$0-181,751
-100.0%
-0.33%
LYB ExitLYONDELLBASELL INDUSTRIES N$0-530,739
-100.0%
-0.44%
FIS ExitFIDELITY NATL INFORMATION SV$0-397,265
-100.0%
-0.48%
TMO ExitTHERMO FISHER SCIENTIFIC INC$0-208,112
-100.0%
-0.59%
AGN ExitALLERGAN PLC$0-374,710
-100.0%
-0.63%
ELAN ExitELANCO ANIMAL HEALTH INC$0-2,618,232
-100.0%
-0.68%
TMUS ExitT MOBILE US INC$0-1,358,164
-100.0%
-0.93%
BA ExitBOEING CO$0-416,863
-100.0%
-1.19%
UNVR ExitUNIVAR SOLUTIONS INC$0-5,765,724
-100.0%
-1.22%
DVA ExitDAVITA INC$0-1,914,754
-100.0%
-1.26%
WMB ExitWILLIAMS COS INC DEL$0-7,844,612
-100.0%
-1.63%
ANTM ExitANTHEM INC$0-751,142
-100.0%
-1.99%
DIS ExitDISNEY WALT CO$0-2,088,178
-100.0%
-2.64%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-05-15
Signatures

The EDGAR filing(s) were signed by:

About Glenview Capital Management

Glenview Capital Management is a well-known investment management firm that was founded in 2001 by Larry Robbins. The company is headquartered in New York City and manages over $10 billion in assets. Glenview Capital Management is known for its long-term investment strategy and its focus on fundamental analysis. The company invests in a wide range of industries, including healthcare, technology, and consumer goods.

Larry Robbins, the CEO and founder of Glenview Capital Management, is a well-respected figure in the finance industry. He has been recognized for his investment expertise and has been featured in numerous publications, including Forbes and The Wall Street Journal. In addition to Robbins, Glenview Capital Management has a team of experienced professionals, including COO Mark Horowitz and Chief Investment Officer Lee Ainslie.

Glenview Capital Management has a strong track record of delivering solid returns to its investors. The company's investment philosophy is centered around identifying undervalued companies with strong fundamentals and holding them for the long-term. This approach has proven successful, as Glenview Capital Management has consistently outperformed the market over the years.

Overall, Glenview Capital Management is a reputable investment management firm with a strong team of professionals and a proven investment strategy. While past performance is not indicative of future results, investors looking for a long-term investment strategy may want to consider Glenview Capital Management as a potential investment option.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TENET HEALTHCARE CORP42Q3 202316.7%
HCA HOLDINGS INC42Q3 20239.1%
MCKESSON CORP40Q3 20238.2%
FLEXTRONICS INTL LTD38Q2 20234.5%
BROOKDALE SR LIVING INC38Q3 20232.1%
MERITOR INC36Q1 20223.0%
FMC CORP34Q2 20236.4%
UNIVERSAL HLTH SVCS INC34Q3 20235.0%
HUMANA INC31Q4 202112.1%
ENDO INTL PLC30Q1 20222.8%

View Glenview Capital Management's complete holdings history.

Latest significant ownerships (13-D/G)
Glenview Capital Management Q1 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Butterfly Network, Inc.February 14, 20239,746,8345.5%
Quantum-Si IncFebruary 14, 20234,249,9563.6%
MERITOR, INC.February 22, 20223,544,3335.0%
ATI Physical Therapy, Inc.Sold outFebruary 14, 202200.0%
Evolv Technologies Holdings, Inc.February 14, 2022749,4610.5%
Velocity Acquisition Corp.Sold outFebruary 14, 202200.0%
Bausch Health Companies Inc.December 13, 202117,078,6574.8%
NewHold Investment Corp.June 04, 20211,114,8626.5%
Longview Acquisition Corp. IIApril 02, 20215,000,0007.2%
HighCape Capital Acquisition Corp.March 15, 20211,033,7398.7%

View Glenview Capital Management's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G2024-01-16
13F-HR2023-11-14
SC 13G2023-11-13
13F-HR2023-08-14
13F-HR2023-05-15

View Glenview Capital Management's complete filings history.

Compare quarters

Export Glenview Capital Management's holdings